| RS2504744456 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504745479 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS2504750956 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504751266 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504751716 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS2504753203 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS2504753330 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504755054 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504756664 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504758932 |
SERPINA1
|
Health Risk |
Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504760831 |
SERPINA1
|
Health Risk |
Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504760939 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS2504761251 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504764413 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS2504764459 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504764814 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504765004 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504765090 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504765197 |
PHF21A
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures, Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures |
| RS2504766330 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504766612 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504768975 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504772664 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504772830 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504775143 |
DUOX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Thyroid dyshormonogenesis 6 |
| RS2504775350 |
SERPINA1
|
Health Risk |
Pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504775604 |
SERPINA1
|
Health Risk |
Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504776767 |
SERPINA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504776911 |
SERPINA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504777565 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504777646 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504778008 |
SERPINA1
|
Health Risk |
Pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504778973 |
SERPINA1
|
Health Risk |
Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504780325 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504780722 |
SERPINA1
|
Health Risk |
Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504781328 |
SERPINA1
|
Health Risk |
Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504784138 |
SERPINA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504785531 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504785818 |
DUOX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS2504785893 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504788999 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504789080 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS2504790843 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504791090 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504791118 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504796812 |
AP4E1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 51, Hereditary spastic paraplegia 51 |
| RS2504803353 |
DUOXA2
|
Health Risk |
Pathogenic |
Thyroglobulin synthesis defect, Thyroglobulin synthesis defect |
| RS2504810072 |
DUOXA2
|
Health Risk |
Pathogenic |
Thyroglobulin synthesis defect, Thyroglobulin synthesis defect |
| RS2504825600 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504834746 |
ALDH1A2
|
Health Risk |
Pathogenic |
Diaphragmatic hernia 4, with cardiovascular defects |
| RS2504837607 |
ALDH1A2
|
Health Risk |
Pathogenic |
Diaphragmatic hernia 4, with cardiovascular defects |
| RS2504862939 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504863002 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504864133 |
CEP152
|
Health Risk |
Likely pathogenic |
— |
| RS2504879322 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504879533 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504880509 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504896841 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504897331 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504897519 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504917048 |
CEP152
|
Health Risk |
Likely pathogenic |
— |
| RS2504930584 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504932216 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504936679 |
CEP152
|
Health Risk |
Likely pathogenic |
— |
| RS2504945051 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2504945525 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2504945945 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2504948607 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2504948671 |
VSX2
|
Health Risk |
Likely pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2504956615 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2504973070 |
VSX2
|
Health Risk |
Likely pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2504973144 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS2504973201 |
VSX2
|
Health Risk |
Likely pathogenic |
— |
| RS2504981401 |
MEIS2
|
Health Risk |
Likely pathogenic |
Cardiac malformation, cleft lip/palate |
| RS2504987137 |
RFX7
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 71 |
| RS2504987146 |
RFX7
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, Intellectual developmental disorder |
| RS2504987254 |
RFX7
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 71 |
| RS2504988812 |
RFX7
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2504989046 |
RFX7
|
Health Risk |
Likely pathogenic |
— |
| RS2504989200 |
RFX7
|
Health Risk |
Likely pathogenic |
RFX7-related disorder, RFX7-related disorder |
| RS2504999773 |
SMAD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2504999997 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505000100 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Aneurysm-osteoarthritis syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505020328 |
UBR7
|
Health Risk |
Likely pathogenic |
Li-Campeau syndrome, Li-Campeau syndrome |
| RS2505026251 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505026270 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505026310 |
SLC12A1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2505026929 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 1, Bartter disease type 1 |
| RS2505027099 |
SLC12A1
|
Health Risk |
Likely pathogenic |
— |
| RS2505034727 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505034797 |
SLC12A1
|
Health Risk |
Likely pathogenic |
— |
| RS2505053163 |
SLC12A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS2505058115 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 1, Bartter disease type 1 |
| RS2505080056 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505085696 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505087341 |
SLC12A1
|
Health Risk |
Likely pathogenic |
— |
| RS2505087651 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505087791 |
SLC12A1
|
Health Risk |
Likely pathogenic |
Bartter syndrome, Bartter disease type 1 |
| RS2505087861 |
SLC12A1
|
Health Risk |
Likely pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS2505093961 |
SLC12A1
|
Health Risk |
Pathogenic |
— |